1. Home
  2. PRAA vs BCYC Comparison

PRAA vs BCYC Comparison

Compare PRAA & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PRA Group Inc.

PRAA

PRA Group Inc.

HOLD

Current Price

$16.57

Market Cap

536.5M

Sector

Finance

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$6.87

Market Cap

438.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAA
BCYC
Founded
1996
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
536.5M
438.4M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PRAA
BCYC
Price
$16.57
$6.87
Analyst Decision
Strong Buy
Buy
Analyst Count
3
11
Target Price
$24.33
$18.73
AVG Volume (30 Days)
495.0K
384.4K
Earning Date
11-03-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,161,679,000.00
$28,339,000.00
Revenue This Year
$5.16
N/A
Revenue Next Year
$8.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.41
N/A
52 Week Low
$12.29
$6.03
52 Week High
$23.97
$21.50

Technical Indicators

Market Signals
Indicator
PRAA
BCYC
Relative Strength Index (RSI) 60.66 47.65
Support Level $15.70 $6.03
Resistance Level $16.57 $7.83
Average True Range (ATR) 0.67 0.43
MACD 0.08 0.11
Stochastic Oscillator 94.44 46.67

Price Performance

Historical Comparison
PRAA
BCYC

About PRAA PRA Group Inc.

PRA Group Inc is a leader in acquiring and collecting nonperforming loans. The company returns capital to banks and other creditors to help expand financial services for consumers in the Americas, Europe, and Australia. It is also engaged in providing fee-based services on class action claims recoveries in the United States. The company's portfolio segments include; Core, which is engaged in purchasing and collecting nonperforming loans, which the originators have not chosen not to pursue, and the Insolvency segment which is engaged in purchasing and collecting nonperforming loans where the customer is involved in a bankruptcy proceeding.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: